Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

81.47
-4.9200-5.70%
Post-market: 81.600.1300+0.16%19:59 EDT
Volume:22.97M
Turnover:1.89B
Market Cap:205.80B
PE:12.09
High:86.27
Open:86.12
Low:81.08
Close:86.39
Loading ...

Tariffs Pose $46 Billion Risk to Pharmaceutical Industry -- Analysis

Dow Jones
·
20 hours ago

Stock Track | Merck Plummets 5% as Trump Threatens New Tariffs on Pharmaceutical Sector

Stock Track
·
22 hours ago

Shares of Some U.S. Drugmakers Down After Trump Says Pharmaceutical Sector Is 'Under Review' for Tariffs

THOMSON REUTERS
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Oil companies, US big banks, fintechs

Reuters
·
Yesterday

BUZZ-US drugmakers fall after Trump's new tariff warnings

Reuters
·
Yesterday

Chinese Drug Evaluation Body Accepts Merck's Application for Clesrovimab

MT Newswires Live
·
Yesterday

NIH Funding Is Drying Up. Drug Discovery Could Go With It. -- Barrons.com

Dow Jones
·
Yesterday

11 Stocks to Buy After the Biotech Bloodbath -- Barrons.com

Dow Jones
·
Yesterday

Merck Investors Have 'Limited Appetite' Returning to the Stock Ahead of Gardasil Reassessment, UBS Says

MT Newswires Live
·
Yesterday

Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath

Dow Jones
·
Yesterday

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption-Heard on the Street -- WSJ

Dow Jones
·
03 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

BUZZ-US drugmakers rise on reprieve from Trump tariffs

Reuters
·
03 Apr

3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months

Motley Fool
·
03 Apr

Shares of US Drugmakers Rise After Tariff Exemption

THOMSON REUTERS
·
03 Apr

Shares of Abbvie up 2.5%, Johnson & Johnson up 2.5%, Merck up 1.9%, Amgen up 2.2%

THOMSON REUTERS
·
03 Apr

LIVE MARKETS-Tariff risks, is pharma out of the woods?

Reuters
·
03 Apr

Pharma Mar Partners with Merck for Japanese Launch of Cancer Drug

TIPRANKS
·
03 Apr

Spanish stocks - Factors to watch on April 3

Reuters
·
03 Apr

Pharma Mar Signs Licensing, Development And Commercialization Agreement With Merck For Lurbinectedin In Japan

Reuters
·
03 Apr